We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Pharmaceutical Chemical Raw Powder CAS 118288-08-7 Lafutidine
Category:Intermediates > Pharmaceutical Intermediates Product Name:Pharmaceutical Chemical Raw Powder CAS 118288-08-7 Lafutidine CAS No.:118288-08-7 Standard:In-house Standards Price(USD):US$50~US$200/Kg Company:SCM Pioneering Co.,Ltd
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Monthly Production Capacity: 10000kg
Contract Manufacturing: CRO,CMO
Packaging Information: 1kg/barrel
Delivery Lead Time: 15-50days
Sample Provided: yes
Payment Terms: T/T
Specification of Analysis
Product Name
Lafutidine Powder
CAS
118288-08-7
Appearance
white powder
Molecular formula
C22H29N3O4S
Molecular Weight
431.55
Assay
98%
Shelf Life
Two years
Storage
Store in a dry, cool and sealed place
What is Lafutidine?
Lafutidine (INN) is a second generation H2 receptor antagonist having multimodal mechanism of action. It is currently marketed in Japan (Stogar) China (Lemeiting) and India (Lafaxid) It not only suppresses gastric acid secretion, but also has cytoprotective properties by the virtue of its property to induce the collagen synthesis in the gastric mucosa. It has a novel mechanism of action in addition to blocking the H2 receptors, it decreases inflammation by modulating calcitonin gene-related peptide (CGRP) and vanilloid receptors It is also found to stimulate mucin biosynthesis and promote the restitution of damaged mucosa.
Function and Application of Lafutidine
Lafutidine (INN) is a second generation H2 receptor antagonist having multimodal mechanism of action.
It is currently marketed in Japan (Stogar) China (Lemeiting) and India (Lafaxid) It not only suppresses gastric
acid secretion, but also has cytoprotective properties by the virtue of its property to induce the collagen
synthesis in the gastric mucosa. It has a novel mechanism of action in addition to blocking the H2 receptors,
it decreases inflammation by modulating calcitonin gene-related peptide (CGRP) and vanilloid receptors It
is also found to stimulate mucin biosynthesis and promote the restitution of damaged mucosa.
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
![N-[(3-cyano-1H-pyrazol-5-yl)methyl]-N-methyl-, 1,1-dimethylethyl ester](https://eimg.pharmasources.com/image/product/20241210/97d427e2962ae05a40a034bd43a341a3jpg!145)
![1H-Benzo[d]imidazole-6-carboxylic acid](https://eimg.pharmasources.com/image/product/20241210/b08033a19baff8288b76ef0640046bf3jpg!145)
